New drug aims to calm rogue immune attacks on blood cells
Disease control
Recruiting now
This early-stage trial tests a new medicine called IASO-782 in 16 adults with two autoimmune blood diseases: immune thrombocytopenia (low platelets) and warm antibody autoimmune hemolytic anemia (low red blood cells). The main goal is to check the drug's safety and how well peopl…
Phase: PHASE1 • Sponsor: Shanghai IASO Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 08, 2026 13:07 UTC